Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel/Carboplatin Chemoradiation in High-risk Cervical Cancer
NCT00340184Phase 2Completed
- Sponsor
- Korean Gynecologic Oncology Group
- Start
- Aug 2004
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in Cervical Cancer (CC), sponsored by Korean Gynecologic Oncology Group. Started Aug 2004; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00340184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00340184.